Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy

The clinical outcome of T-cell non-Hodgkin lymphoma (NHL) is poor and innovative treatments are needed. Tenascin-C is a large extracellular glycoprotein not expressed under physiological conditions, but overexpressed in cancer. Aim of the study was to evaluate tenascin-C expression within pathologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gritti, Giuseppe, Gianatti, Andrea, Petronzelli, Fiorella, De Santis, Rita, Pavoni, Chiara, Rossi, Riccardo Lorenzo, Cattaneo, Laura, Spagnoli, Luigi Giusto, Ferrari, Silvia, Rossi, Andrea, Barbui, Anna Maria, Rambaldi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839400/
https://www.ncbi.nlm.nih.gov/pubmed/29515769
http://dx.doi.org/10.18632/oncotarget.23919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839400/
https://www.ncbi.nlm.nih.gov/pubmed/29515769
http://dx.doi.org/10.18632/oncotarget.23919

Ejemplares similares